Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: J Infect Dis. 2010 Aug 15;202(3):386–391. doi: 10.1086/653705

Figure 2.

Figure 2

Cross-sectional analysis of the correlation between (A) percent memory CD4 T cells positive for Casp8p41 and absolute CD4 T cell counts (r = −0.31, P = .03) or (B) between human immunodeficiency virus level and absolute CD4 T cell counts (r = 0.006, P = .97) in 53 HIV-infected patients with active viral replication. Correlation coefficients calculated by Spearman Rank test. *P < .05 was considered statistically significant. Casp8p41 content was measured longitudinally in previously antiretroviral naive HIV-infected patients who started antiretroviral therapy and compared with the CD4 T cell count. Representative plots of the percentage memory CD4 T cells positive for Casp8p41 (circles) and CD4 T cell counts (squares) a patient with consistently decreasing Casp8p41 content (C), or a patient with increasing Casp8p41 content (D).